SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000929638-24-002175
Filing Date
2024-06-13
Accepted
2024-06-13 16:38:16
Documents
1
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 12851
  Complete submission text file 0000929638-24-002175.txt   16252
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Reporting) CIK: 0001583977 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40335 | Film No.: 241041789

Mailing Address C/O CORMORANT ASSET MANAGEMENT, LP 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address
Chen Bihua (Reporting) CIK: 0001599214 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40335 | Film No.: 241041792

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 617-848-3429
Cormorant Global Healthcare Master Fund, LP (Reporting) CIK: 0001618442 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40335 | Film No.: 241041791

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0370
Cormorant Private Healthcare Fund III LP (Reporting) CIK: 0001817320 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40335 | Film No.: 241041790

Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Issuer) CIK: 0001840439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)